Form D · Biotechnology
Cyto Wave Technologies Inc.
San Francisco, CA · CIK 0001562107
Offering snapshot reported Apr 4, 2013 · SEC filing
- Reported sold
- $965K Offering amount: $1M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Sep 14, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 4, 2013 | Initial | $965,000 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-194495
The offering is now closed
This offering was done by company officers without commission or cost
Source: Form D, filed Apr 4, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Callahan | Director |
| Anchie Kuo | Director, Executive |
| George Yu | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
201 Spear Street, Suite 1100
San Francisco, CA, 94105
San Francisco, CA, 94105